James Yamanaka - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Neuren Pharmaceuticals (ASX: NEU) gains fourth US orphan drug designation for NNZ-2591

Coursera (NYSE: COUR) plunges 26% as Udemy savings accelerate. Where is the growth?

Trump administration loses Alaska Senate ballot case as judge rejects election delay

Whitehaven Coal’s A$1bn Winchester South project clears major court hurdle but approvals remain outstanding

Read More

Healthcare Industry News

How Organigram Global hopes new CEO James Yamanaka will accelerate brand and export strategy

Organigram Global names ex-BAT strategist James Yamanaka CEO, marking a strategic shift toward global growth. Find out what it means for investors today.

byPallavi Madhiraju

November 25, 2025

web analytics